Drug
Aripiprazole Depot
Aripiprazole Depot: highest development phase Phase 3, developed by Otsuka. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Otsuka
Trials
| Drug | Phase | Indication |
|---|---|---|
| Aripiprazole (Abilify®) IM Depot Injection NCT01509053 | Phase 3 | Schizophrenia |
Latest
No recent events.
Follow Aripiprazole Depot on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.